Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

Epigallocatechin-3-gallate ÇÔÀ¯ ¥â-TCPÀ̽ÄÀçÀÇ °ñÀç»ý´É¿¡ °üÇÑ Á¶Á÷°èÃøÇÐÀû Æò°¡

Histomorphometric evaluation of bone healing capacity of epigallocatechin-3-gallate-loaded ¥â-TCP bone substitute in rabbit calvarial defects

´ëÇÑÄ¡°úÀç·áÇÐȸÁö 2018³â 45±Ç 3È£ p.155 ~ 167
¹ÚÁø¿ì,
¼Ò¼Ó »ó¼¼Á¤º¸
¹ÚÁø¿ì ( Park Jin-Woo ) - °æºÏ´ëÇб³ Ä¡ÀÇÇÐÀü¹®´ëÇпø Ä¡ÁÖ°úÇб³½Ç

Abstract

º» ¿¬±¸¿¡¼­´Â ¹Ì¼¼´Ù°ø¼º ¥â-tricalcium phosphate (¥â-TCP)À̽ÄÀç¿¡ ³ìÂ÷¿±ÃßÃâ »ý¸®È°¼º¹°ÁúÀÎ epigallocatechin-3-gallate (EGCG) °áÇսà À̽ÄÀçÀÇ °ñÀç»ý´ÉÀÌ ÁõÁøµÇ´ÂÁö È®ÀÎÇϱâ À§ÇØ °¡ÅäÀÇ µÎ°³°ñ °á¼Õ¸ðµ¨À» ÀÌ¿ëÇÏ¿© °ñÄ¡À¯¾ç»óÀ» Æò°¡ÇÏ¿´´Ù. EGCG°¡ ÇÔÀ¯µÈ À̽ÄÀçÀÇ °ñÄ¡À¯´ÉÀ» Æò°¡Çϱâ À§ÇØ ÀÔÀÚÇü ¥â-TCP 200 mg¿¡ 1 mg (TCP-1±º), 10 mg (TCP-10±º)ÀÇ µÎ °¡Áö ¿ë·®À¸·Î EGCG°¡ Àû¿ëµÈ ½ÇÇ豺 À̽ÄÀ縦 ÁغñÇÏ¿© EGCG°¡ °áÇÕµÇÁö ¾ÊÀº ´ëÁ¶±º ¥â-TCP (TCP-0±º)¿Í ºñ±³ÇÏ¿© 4ÁÖ, 8ÁÖÀÇ Ä¡À¯±â°£¿¡¼­ ½Å»ý°ñ Çü¼º·®À» Á¶Á÷°èÃøÇÐÀûÀ¸·Î Æò°¡ÇÏ¿´´Ù. °¡ÅäÀÇ µÎ°³°ñ¿¡ Çü¼ºÇÑ Á÷°æ 8 mmÀÇ °ñ°üÅë °á¼ÕºÎ¿¡ ¼¼ Á¾·ùÀÇ À̽ÄÀ縦 ÃæÁøÇÑ ÈÄ Ä¡À¯¾ç»óÀ» Æò°¡ÇÑ °á°ú °á¼ÕºÎ´ç 1 mgÀÇ EGCG°¡ Àû¿ëµÈ TCP-1±ºÀº ´Ù¸¥ µÎ ±º¿¡ ºñÇØ À̽ĺγ»¿¡¼­ ÇöÀúÈ÷ ÁõÁøµÈ ½Å»ý°ñ Çü¼º °á°ú¸¦ ³ªÅ¸³»¾úÀ¸¸ç, Àç»ýµÈ °ñÁ¶Á÷³»¿¡¼­ ¸¹Àº ½Å»ý Ç÷°üÀÌ Çü¼ºµÈ °ÍÀ» È®ÀÎÇÒ ¼ö ÀÖ¾ú´Ù. TCP-1±ºÀº EGCG¸¦ Àû¿ëÇÏÁö ¾ÊÀº ´ëÁ¶±º TCP-0±º¿¡ ºñÇØ 4ÁÖ, 8ÁÖ Ä¡À¯±â°£¿¡¼­ ÇöÀúÈ÷ Áõ°¡µÈ ½Å»ý°ñ ¸éÀûÀ» ³ªÅ¸³»¾ú°í(p < 0.05), TCP-10±º¿¡ ºñÇؼ­µµ ÀÌ½Ä 8ÁÖÈÄ ½Å»ý°ñ ¸éÀûÀÌ Áõ°¡ÇÑ °á°ú¸¦ º¸¿´´Ù(p < 0.05). ÀÌ¿¡ ºñÇØ °í¿ë·®ÀÇ EGCG°¡ Àû¿ëµÈ TCP-10±º°ú EGCG°¡ Àû¿ëµÇÁö ¾ÊÀº TCP-0±º »çÀÌ¿¡ ½Å»ý°ñ Çü¼º·®¿¡ À־ À¯ÀÇÇÑ Â÷ÀÌ´Â ¾ø¾ú´Ù. ÀÌ·¯ÇÑ º» ¿¬±¸ÀÇ °á°ú¸¦ ÅëÇØ ´Ü¼øÈíÂøÀ» ÅëÇØ 1 mgÀÇ EGCG°¡ °áÇÕµÈ ¥â-TCPÀ̽ÄÀç´Â °¡ÅäÀÇ µÎ°³°ñ °á¼Õ¸ðµ¨ÀÇ Ä¡À¯¿¡¼­ °ñÀç»ýÀ» ÃËÁøÇϴµ¥ È¿°úÀûÀÓÀ» È®ÀÎÇÒ ¼ö ÀÖ¾ú´Ù. µû¶ó¼­ ÀûÁ¤¿ë·®ÀÇ ±¹¼ÒÀû EGCGÀû¿ëÀº °ñ°á¼Õ Ä¡·á¿¡ »ç¿ëµÇ´Â ¥â-TCPÀ̽ÄÀçÀÇ °ñÀç»ý´ÉÀ» ÁõÁøÇÏ´Â È¿°úÀûÀÎ Á¢±Ù¹ýÀÌ µÉ ¼ö ÀÖÀ» °ÍÀ¸·Î ±â´ëµÈ´Ù.

TCP-1 filled defects at 8 weeks. Histomorphometric analysis revealed significantly greater newly formed bone area in the TCP-1 group when compared with unloaded TCP-0 (p<0.05 at 4 and 8 weeks) and 10 mg EGCG-loaded TCP-10 groups (p<0.05 at 8 weeks). No difference was observed in new bone area between TCP-0 and TCP-10 groups. These results suggest that local delivery of 1 mg EGCG to ¥â-TCP bone substitute by simple adsorption promotes bone regeneration in the healing of rabbit calvarial osseous defect and higher EGCG dose (in this study, 10 mg per defect) does not exert any positive effect on bone healing capacity of ¥â-TCP. Thus, local delivery of EGCG to ¥â-TCP bone substitute seems to be an effective approach for the treatment of osseous defects.

Å°¿öµå

°ñ´ëüÀç; °ñÀç»ý; EGCG; Á¶Á÷°èÃø; Æú¸®Æä³î
Bone substitute; Bone regeneration; EGCG; Histomorphometry; Polyphenol

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

 

µîÀçÀú³Î Á¤º¸

KCI